Stay safe with our range of anti-malaria treatments
Malaria is a serious, sometimes life-threatening disease spread by mosquito bites in tropical and subtropical regions — including Sub-Saharan Africa, South America, Asia, and parts of India.
Symptoms typically include fever, headache, chills, muscle pain, fatigue, and vomiting. While malaria is preventable and treatable, it requires the right medication before and during travel to high-risk areas.
Our range of clinically proven anti-malaria treatments provides safe, effective protection for travellers. These prescription medicines prevent malaria parasites from developing in the bloodstream, offering vital protection throughout your trip.
At ifeelshy®, we stock trusted anti-malarial tablets including Malarone, Lariam, and Atovaquone/Proguanil, all MHRA-approved and sourced from reputable UK manufacturers.
If you’re planning to travel abroad, start your consultation today to ensure you receive the most suitable medication based on your destination and medical history.
Malaria is caused by Plasmodium parasites transmitted through mosquito bites. The parasites enter the bloodstream and infect red blood cells, leading to fever and other symptoms.
They prevent malaria parasites from developing in the blood, protecting you from infection when bitten by infected mosquitoes.
Most tablets should be started 1–2 days before travel and continued for up to 7 days after leaving the malaria-risk area (depending on the medicine).
Malarone, Lariam, Doxycycline, and Atovaquone/Proguanil are widely used. The best choice depends on your destination, trip length, and medical history.
Mild side effects such as nausea or dizziness can occur but are usually short-lived. Taking the tablets with food or at the same time each day helps reduce this.
Visit the NHS Fit for Travel or TravelHealthPro websites for destination-specific advice, or start a consultation to receive tailored guidance.
Fill in our online questionnaire so our medical team can show you eligible hair loss treatments.
Start consultationNo related articles available for this category.